METMetLife
$98.31+27% 1Y
$98.31
$67.1952 weeks$100.01
MET as reported
MetLife reported $79.4B of revenue over the trailing twelve months, +8.7% on the year before. 7 reported series are charted on this page, each one as filed.
$79.4B
Revenue, trailing twelve months · to Q2 2026 · +8.7% against the twelve months before
- Net income
- $3.63B
Net income · −15% year on year · trailing twelve months to Q2 2026
- EPS
- $5.22
EPS · −11% year on year · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $79.4B | +8.7% | Q2 2026 |
| Net income | $3.63B | −15% | Q2 2026 |
| EPS | $5.22 | −11% | Q2 2026 |
| Net margin | 4.7% | n/a | Q2 2026 |
| ROE | 13% | n/a | Q2 2026 |
| ROA | 0.49% | n/a | Q2 2026 |
| P/E | 18.8 | n/a | today |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.

MetLife (MET) · Revenue and profitRevenue and profitMetLife (MET)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
On our screens:Stocks that buy back more than they dilute
Insurance, Life
The closest names by size in the same industry